10x Genomics, Inc. TXG Business Segments
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| Total Revenue by Product | ||||||
| Spatial | $153.64M+22.0% | $143.98M+18.9% | $138.81M+29.1% | $133.11M+44.8% | $125.96M+69.4% | |
| Revenue by Product | ||||||
| License and royalty revenue | $30.02M+72.7% | $46.14M+14,272% | $45.91M+21,760% | $45.02M+39,045% | $17.38M+1,737,900% | |
| Products and services revenue | $608.76M+0.2% | $596.69M-2.3% | $595.91M-0.7% | $599.45M-0.6% | $607.28M+0.4% | |
| Services | $33.91M+26.7% | $32.73M+34.6% | $31.28M+38.7% | $29.45M+43.0% | $26.75M+47.1% | |
| Spatial | $31.25M-36.0% | $34.11M-40.7% | $38.17M-46.5% | $42.51M-48.5% | $48.8M-43.0% | |
| Revenue by Geography | ||||||
| Americas (excluding United States) | $11.92M-9.8% | $12.26M-8.8% | $11.98M-20.3% | $12.45M-16.1% | $13.21M-9.4% | |
| Asia-Pacific (excluding China) | $54.59M+12.0% | $52.07M+13.3% | $50.06M-0.7% | $48.7M-1.9% | $48.76M-6.2% | |
| China | $69.22M+14.9% | $70.26M+22.6% | $69.85M+28.3% | $69.69M+34.4% | $60.26M+18.5% | |
| Europe, Middle East and Africa | $166.67M+6.2% | $161.72M+1.2% | $158.08M-1.5% | $154.31M-0.2% | $156.94M+5.6% | |
| United States | $336.39M-2.6% | $346.51M+3.6% | $351.84M+0.7% | $359.32M-0.4% | $345.5M-3.9% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does 10x Genomics, Inc. break its business down?
- 10x Genomics, Inc. (TXG) reports total revenue by product across 2 parts — Single Cell and Spatial. Each is extracted from the segment footnotes and tracked over time.
- Where does 10x Genomics, Inc.'s segment data come from?
- Segment breakdowns are pulled from the segment footnotes in 10x Genomics, Inc.'s SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.